Radiometer logo

Clinical impact of accurate hemoglobin monitoring in surgical and critical care settings

December 6, 2017

Webinar presented by Dr. Nam K. Tran, Assistant Adjunct Professor, University of California, Davis

Recording and slides

About this webinar

Not all hemoglobin measurement methods provide quality results. Choosing the incorrect device and not understanding performance limits can result in unnecessary blood utilization and excess cost. This webinar will discuss the strengths and benefits of each method, and highlight confounding factors of blood gas analysis. Strategies to minimize preanalytical errors will also be discussed and evidence will be provided on the clinical impact of accurate hemoglobin testing in surgical and intensive care unit patients. 

About the speaker

Dr. Tran received his B.S. degree in Biochemistry and Molecular Biology in 2003 from UC Davis. In 2008, he completed his Ph.D. in Comparative Pathology from UC Davis. He served as a postdoctoral scholar at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at UC Davis – Lawrence Livermore Point-of-Care Technologies Center from 2009 to 2011. During this time he also completed a M.S. in Pharmacology and Toxicology.

In 2011, he was recognized for his contributions to the field of clinical chemistry and was voted into the membership of National Academy of Clinical Biochemistry. In the same year, he was also accepted to the National Institutes of Health, funded Clinical and Translational Science Center’s (CTSC) K30, and mentored Clinical Research Training Program (MCRTP) to further his research training in burn critical care.

Currently, Dr. Tran serves as Assistant Clinical Professor in the Clinical Chemistry and Point-of-Care Testing Sections for the Department of Medical Pathology and Laboratory Medicine, and as a National Heart Lung and Blood Institute Emergency Medicine K12 Scholar. Dr. Tran is also the Principal Investigator for the American Burn Association Sepsis Trial [multicenter, randomized, controlled trial] and Instructor of Record for Clinical Chemistry/POCT for the Pathology and Laboratory Medicine residency program at UC Davis School of Medicine.

Who should attend?

  • Laboratorians
  • Point-of-care coordinators
  • Respiratory therapists
  • Nurses


Continuing education

For US participants:

  • One PACE® credit will be provided for each session. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. 
  • Each session is approved for 1 Florida CE credit
  • Florida Board of Clinical Laboratory Personnel approved number: 50-12563
  • This program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC)

 

This webinar will:

  • Describe total hemoglobin methods used in laboratory and point-of-care settings
  • Identify confounding factors that may result in inaccurate total hemoglobin measurement
  • Identify the cost associated with inaccurate hemoglobin measurements as it relates to transfusion practice
  • Discuss solutions that provide accurate monitoring of total hemoglobin in critical care and surgical settings

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)

ABOUT THIS POLICY

Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.


Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.

SCOPE

This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.


There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.

Read more